Skip to main content

Day: June 22, 2020

Contango Announces First Quarter 2020 Financial Results

HOUSTON, June 22, 2020 (GLOBE NEWSWIRE) — Contango Oil & Gas Company (NYSE American: MCF) (“Contango” or the “Company”) announced today its financial results for the first quarter ended March 31, 2020. First Quarter 2020 HighlightsProduction of 1,720 Mboe for the quarter, or 18.9 Mboe per day, a 216% increase from the 6.0 Mboe per day in the prior year quarter, primarily due to additional production from the properties acquired from White Star Petroleum, LLC and certain affiliates (collectively, “White Star”) and Will Energy Corporation (“Will Energy”) in the fourth quarter of 2019.Initiated flowback from the State Spearhead #1H well in Pecos County, Texas, in the Southern Delaware Basin, in January 2020.Net loss of $105.3 million (including $145.9 million in pre-tax impairments), compared to a net loss of $8.6 million in the...

Continue reading

Corbus Pharmaceuticals Reports Last Subject Visit in Phase 2b Study of Lenabasum for Treatment of Cystic Fibrosis

Topline data on schedule for Q3 2020Reduction in pulmonary exacerbations (PEx) as primary endpointStudy enrolled 426 participants regardless of CFTR mutation or background CFTR-targeting therapiesTreatment of inflammation to reduce PEx remains a key unmet need in CFStudy is funded in part by a Development Award for up to $25 Million from the Cystic Fibrosis FoundationNorwood, MA, June 22, 2020 (GLOBE NEWSWIRE) — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced that the last subject completed their final visit in the Company’s Phase 2b JBT101-CF-002 trial of lenabasum for the treatment of cystic fibrosis. Topline results from the study are on track to readout in the...

Continue reading

Ceapro Announces Results of 2020 Shareholders’ Meeting

EDMONTON, Alberta, June 22, 2020 (GLOBE NEWSWIRE) — Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced today that all proposed Directors were elected to serve for a one-year term at its Annual General and Special Meeting of Shareholders held on June 19, 2020 as per the following results:All other matters at the Shareholders’ meeting, namely the appointment of auditors and the re-approval and ratification of the Company’s Stock Option Plan, as proposed in the Company’s information circular dated April 30, 2020, were also approved by shareholders.About Ceapro Inc.Ceapro Inc. is a Canadian biotechnology company involved in the development of proprietary...

Continue reading

Kirkland Lake Gold Announces Management Appointments

TORONTO, June 22, 2020 (GLOBE NEWSWIRE) — Kirkland Lake Gold Ltd. (“Kirkland Lake Gold” or the “Company”) (TSX:KL) (NYSE:KL) (ASX:KLA) today announced a number of management appointments intended to enhance the depth and effectiveness of the Company’s leadership team as it moves forward as a leading senior gold producer with industry-leading financial performance and strength. All appointments listed below are effective immediately.Among the appointments:Greg Gibson joins the Company as Special Advisor to the CEO, Business Process Improvement;Natasha Vaz is promoted to Senior Vice President, Technical Services and Innovation from her current position of Vice-President, Technical Services;Jennifer Wagner is promoted to Senior Vice President, Corporate Affairs, Legal Counsel and Corporate Secretary from Vice President, Legal;Mark...

Continue reading

Veroni Brands Receives FINRA Approval on 15c2-11 Filing Company’s Trading Symbol: VONI

Bannockburn, IL, June 22, 2020 (GLOBE NEWSWIRE) — (“Veroni” or the “Company”) (OTCBB:VONI), an importer of premium beverage, chocolate and snack products produced in Europe, which sells and distributes to domestic and international retailers, has received approval from the Financial Industry Regulatory Authority (“FINRA”) to quote and trade the Company’s securities on the OTC Markets.The Company has satisfied the requirements of Rule 15c2-11 and has been assigned the trading symbol OTCBB: VONI, enabling the Company’s Market Maker to quote the Company’s securities on the Over-the-Counter Bulletin Board. The Company is now within the regulatory 30-day time frame to be cleared for other market makers to participate.Igor Gabal, President and CEO, stated, “This marks a significant milestone in the rapid growth of Veroni Brands. ...

Continue reading

Silver Bear Vertikalny and Mangazeisky North Resource Revision

TORONTO, June 22, 2020 (GLOBE NEWSWIRE) — Silver Bear Resources Plc (“Silver Bear” or the “Company”) (TSX: SBR) announces that it has now received a draft report from Wardell Armstrong (Moscow) that provides a review of the Company’s current mineral resources, as well as draft revised mine and processing plans, for its Vertikalny and Mangazeisky North deposits (“Draft WA Report”). Silver Bear had previously disclosed that it had engaged Wardell Armstrong (Moscow) to conduct this review of the mineral resources as well as revised mine and processing plans for these deposits.The Draft WA Report presents a potential material change to the current mineral resources at these deposits. Given the potential material changes to the mineral resource estimates for both Vertikalny and Mangazeisky North deposits and the scope of the project...

Continue reading

GasLog Ltd. Announces Completion of Private Placement of Common Shares

Piraeus, Greece, June 22, 2020 (GLOBE NEWSWIRE) — GasLog Ltd. (“GasLog” or “the Company”) (NYSE: GLOG) today announced that the company has sold 14,400,000 common shares at a price of $2.50 per share for total gross proceeds of $36.0 million through a private placement of unregistered common shares (the “Private Placement”). The net proceeds of the Private Placement are expected to be used for general corporate purposes. Approximately 75% of shares issued in the Private Placement were purchased by GasLog’s directors and affiliates, including 6,500,000 common shares purchased by Blenheim Holdings Ltd, wholly owned by the Livanos family and 4,000,000 common shares purchased by a wholly owned affiliate of the Onassis Foundation. In addition, members of the Tung family, whose roots in shipping date back over 70 years, purchased common...

Continue reading

Ipsidy is Selected by PharmacyID to Deliver a High Assurance Identity Verification Solution in Australia

LONG BEACH, NY and ESSENDON, AUSTRALIA, June 22, 2020 (GLOBE NEWSWIRE) — Ipsidy Inc. (www.ipsidy.com) [OTCQB: IDTY], a leading provider of secure, mobile biometric identity solutions, including Identity as a Service (IDaaS) and PharmacyID, (www.pharmacyid.com.au) which operates a platform offering a trusted identity verification service through a network of over 2,500 pharmacies, have signed a partnership agreement to create an identity verification solution, with the highest level of assurance for the Australian market.PharmacyID has over twenty years of experience in Australia and is accredited by the Australian Criminal Intelligence Commission (ACIC) to provide Police background check services and the Department of Home Affairs, Document Verification Service (DVS). PharmacyID seeks to enhance its current customer identity verification...

Continue reading

Compass Discovers Second High-Grade Bedrock Gold Zone on the Samagouela Trend

TORONTO, June 22, 2020 (GLOBE NEWSWIRE) — Compass Gold Corp. (TSX-V: CVB) (Compass or the Company) is pleased to provide an update on the recently completed drilling at the Samagouela and Samagouela South prospects, located on the Company’s Kourou permit within the Sikasso Property in Southern Mali (Figure 1).HighlightsGeophysical survey and drilling at Samagouela identify a pronounced, broad, shallow gold target, associated with a shear zone, extending more than 2-kilometresAir core drilling (24 AC holes, 1,253 m) intersects gold mineralization within two wide trendsBest interval at Samagouela: 9 m at 5.79 g/t Au (from 45 m, and remains open at depth), including 1 m @ 36.37 g/t Au (from 45m)Best interval at Samagouela South: 14 m at 2.75 g/t Au (from 20 m), including 1 m @ 11.64 g/t Au (from 21 m)Further geophysical testing planned...

Continue reading

New Data Show Theratechnologies’ SORT1+ Technology is Effective in Many Treatment-Resistant Cancers

Peptide-drug conjugates TH1902 and TH1904 show significant reduction in the formation of vasculogenic mimicry by targeting the sortilin receptorCurcumin shows increased anticancer activity when conjugated to proprietary peptideSORT1+ technology significantly widens therapeutic window of traditional cytotoxic cancer treatmentsMONTREAL, June 22, 2020 (GLOBE NEWSWIRE) — Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, is pleased to announce that new data featuring its investigational sortilin 1 (SORT1)-targeting peptide-drug conjugate technology will be presented in three posters at the American Association for Cancer Research’s virtual annual meeting II.“We believe that our SORT1+ technology is one of the most promising advances in the treatment of cancer in many years....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.